Ulfaz T 1000mg/125mg Injection
Marketer
Arlak Biotech Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Ulfaz T 1000mg/125mg Injection
Combiflox 1000mg/125mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, curbing infection spread. Administration must be solely under a physician's guidance; adhere strictly to the prescribed schedule. Complete the entire treatment course, even with symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) demand prompt emergency care. Inform your doctor of all current medications prior to use. Pregnant or lactating individuals require physician consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operation of vehicles if drowsiness or dizziness occurs. Adequate rest, nutritious food, and hydration contribute to faster recovery. Laboratory monitoring may be implemented to assess treatment response.
Primary Ingredients of Ulfaz T 1000mg/125mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Ulfaz T 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ulfaz T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Ulfaz T 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ulfaz T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ulfaz T 1000mg/125mg Injection works:
Ceftriaxone/Tazobactum (Ulfaz T 1000mg/125mg Injection) combines a cephalosporin antibiotic, Ceftriaxone, with the beta-lactamase inhibitor, Tazobactum. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thus augmenting Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Ulfaz T 1000mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Ulfaz T 1000mg/125mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to fetuses; clinical data in humans, however, remain scarce.
Breast feedingCAUTION
Administering Ulfaz T 1000mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ulfaz T 1000mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from driving if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ulfaz T 1000mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Ulfaz T 1000mg/125mg Injection to individuals with severe hepatic impairment requires careful consideration. Dosage modification of Ulfaz T 1000mg/125mg Injection might be necessary; physician consultation is advised. Altering the Ulfaz T 1000mg/125mg Injection dosage is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ulfaz T 1000mg/125mg Injection :
Should you forget a scheduled dose of Ulfaz T 1000mg/125mg Injection, seek medical advice.
Facts to Know About Ulfaz T 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently